Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01530386 · ClinicalTrials.gov registry record · Phase 1
A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects
A Phase 1 study of Healthy Subjects, sponsored by UCB Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
- 4
- Study locations
NCT01530386 is a Phase 1 study of Healthy Subjects that has completed, run by UCB Pharma. The registered enrollment target is 25 participants, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (80% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT01530386, a Phase 1 study of Healthy Subjects, has completed, sponsored by UCB Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
- 4
- Study locations
Study Summary
The effects of Lacosamide, an antiepileptic drug, on sleep have not been formally evaluated. The present study is being conducted to assess the effects of Lacosamide on sleep quality in healthy subjects.
Conditions Studied
Interventions
- DRUG Lacosamide
Study Locations (4)
Arkansas
- 005 - Little Rock
Ohio
- 003 - Cleveland
Texas
- 004 - Austin
Virginia
- 001 - Fredericksburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01530386
The ClinicalTrials.gov registry entry for NCT01530386 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 128-participant average among 69 other Healthy Subjects trials with a reported enrollment target (80% lower). The listed sponsor is UCB Pharma, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 1 intervention - of which Lacosamide is the first listed.
NCT01530386 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Arkansas, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT01530386 about?
NCT01530386 is a clinical study titled "A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects". The effects of Lacosamide, an antiepileptic drug, on sleep have not been formally evaluated. The present study is being conducted to assess the effects of Lacosamide on sleep quality in healthy subjects.
What is the current status of trial NCT01530386?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2012-01. Estimated completion is 2012-07.
What conditions does trial NCT01530386 study?
This clinical trial studies the following conditions: Healthy Subjects.
What interventions are being tested in trial NCT01530386?
The interventions under investigation include: Lacosamide (DRUG).
Who is sponsoring clinical trial NCT01530386?
This trial is sponsored by UCB Pharma, which has 100 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01530386 being conducted?
This trial has 4 study locations across Arkansas, Ohio, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I Study of ICP-332 in Healthy Subjects
RECRUITING · Phase 1
-
A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects
RECRUITING · Phase 1
-
Phase 1 Study of Intravaginal KB15A
RECRUITING · Phase 1
-
A Study to Compare to the Pharmacokinetic Profile of Two Paracetamol Formulations
COMPLETED · Phase 1
-
Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®
COMPLETED · Phase 1
-
A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.